Figure 4.

CSF Tau cleaved by caspase 6 (TauΔCasp6) levels of Parkinson disease (PD) and multiple sclerosis (MS) patients are significantly lower than those of Alzheimer disease (AD) patients. Levels of CSF TauΔCasp6 in AD (n = 5) vs. MS (n = 5) and PD (n = 5) cases. ***p < 0.001 vs. AD (one-way ANOVA followed by a Tukey-Kramer post hoc analysis).